Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase-B receptors

Regulatory Peptides

Volumn 108, Issue 2-3, 2002, Pages 63-72

  Guidone, Gabriela ^a   Müller, Dieter ^a   Vogt, Karin ^a   Mukhopadhyay, Amal K ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cyclic nucleotides; Desensitization; Erectile function; Impotence; Penis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; GUANYLATE CYCLASE; GUANYLATE CYCLASE B RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; RECEPTOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ERECTILE DYSFUNCTION; GENE EXPRESSION; MALE; NONHUMAN; PENIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; NATRIURETIC PEPTIDE, C-TYPE; NITROPRUSSIDE; PENIS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 0037107450     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00107-6     Document Type: Article

References (42)

1. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science. 257:1992;401-403.
2. Andersson K.E., Wagner G. Physiology of penile erection. Physiol. Rev. 75:1995;191-236.
3. Ignarro L.J., Bush P.A., Buga G.M., Wood K.S., Fukuto J.M., Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170:1990;843-850.
4. Juenemann K.P., Lue T.F., Luo J.A., Jadallah S.A., Nunes L.L., Tanagho E.A. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study. J. Urol. 138:1987;871-877.
5. Hedlund P., Alm P., Ekstrom P., Fahrenkrug J., Hannibal J., Hedlund H.et al. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum. Br. J. Pharmacol. 116:1995;2258-2266.
6. Ottesen B., Wagner G., Virag R., Fahrenkrug J. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. Br. Med. J. (Clin. Res. Ed.). 288:1984;9-11.
7. Dinsmore W.W., Alderdice D.K. Vasoactive intestinal polypeptide and phentolamine mesylate administered by autoinjector in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents. Br. J. Urol. 81:1998;437-440.
8. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L.et al. Isolation of a novel 38 residue-hypothalamic polypeptide witch stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574.
9. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M.et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170:1990;643-648.
10. Campbell R.M., Scanes C.G. Evolution of the growth hormone-releasing factor (GRF) family of peptides. Growth Regul. 2:1992;175-191.
11. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R.et al. International union of pharmacology: XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
12. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
13. Couvineau A., Rouyer-Fessard C., Darmoul D., Maoret J.J., Carrero I., Ogier-Denis E.et al. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200:1994;769-776.
14. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
15. Cai Y., Xin X., Shim G.J., Mokuno Y., Uehara H., Yamada T.et al. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells. Endocrinology. 138:1997;2515-2520.
16. Pantaloni C., Brabet P., Bilanges B., Dumuis A., Houssami S., Spengler D.et al. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J. Biol. Chem. 271:1996;22146-22151.
17. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H.et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
18. Kim N.N., Huang Y.H., Goldstein I., Bischoff E., Trais A.M. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor. Life Sci. 69:2001;2249-2256.
19. Kim S.Z., Kim S.H., Park J.K., Koh G.Y., Cho K.W. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J. Urol. 159:1998;1741-1746.
20. Potter L.R., Hunter T. Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J. Biol. Chem. 276:2001;6057-6060.
21. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
22. Borboni P., Porzio O., Pierucci D., Cicconi S., Magnaterra R., Federici M.et al. Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)/vasoactive intestinal polypeptide receptors in pancreatic beta-cells and effects of PACAP-38 on components of the insulin secretory system. Endocrinology. 140:1999;5530-5537.
23. Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H.et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 252:1991;120-123.
24. Müller D., Middendorff R., Olcese J., Mukhopadhyay A. Central nervous system-specific glycosylation of the type A natriuretic peptide receptor. Endocrinology. 143:2002;23-29.
25. Vaillancourt P., Omer S., Deng X.F., Mulay S., Varma D.R. Differential effects of rat pregnancy on uterine and lung atrial natriuretic factor receptors. Am. J. Physiol. 274:1998;E52-E56.
26. Müller D., Olcese J., Mukhopadhyay A.K., Middendorff R. Guanylyl cyclase-B represents the predominant natriuretic peptide receptor expressed at exceptionally high levels in the pineal gland. Mol. Brain Res. 75:2000;321-329.
27. Polak J.M., Gu J., Mina S., Bloom S.R. Vipergic nerves in the penis. Lancet. 2:1981;217-219.
28. Willis E., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol. Scand. 113:1981;545-547.
29. Willis E.A., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Life Sci. 33:1983;383-391.
30. Hedlund P., Alm P., Hedlund H., Larsson B., Andersson K.E. Localization and effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in human penile erectile tissue. Acta Physiol. Scand. 150:1994;103-104.
31. Amenta F., Cavallotti C., De Rossi M., Ferrante F., Geppetti P. Vasoactive intestinal polypeptide levels and distribution in the penis of old rats. J. Neural Transm. 70:1987;137-143.
32. Shen Z.J., Lu Y.L., Chen Z.D., Chen F., Chen Z. Effects of androgen and ageing on gene expression of vasoactive intestinal polypeptide in rat corpus cavernosum. BJU Int. 86:2000;133-137.
33. Crowe R., Lincoln J., Blacklay P.F., Pryor J.P., Lumley J.S., Burnstock G. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. A comparison between streptozotocin-treated rats and man. Diabetes. 32:1983;1075-1077.
34. Gu J., Polak J.M., Lazarides M., Morgan R., Pryor J.P., Marangos P.J.et al. Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men. Lancet. 2:1984;315-318.
35. Lincoln J., Crowe R., Blacklay P.F., Pryor J.P., Lumley J.S., Burnstock G. Changes in the VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males. J. Urol. 137:1987;1053-1059.
36. Stepan H., Leitner E., Bader M., Walther T. Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice. Regul. Pept. 95:2000;81-85.
37. Lucas K.A., Pitari G.M., Kazernounian S., Ruiz-Stewart I., Park J., Schulz S.et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52:2000;375-413.
38. McArdle C.A., Ivell R., Käppler K., Müller D., Schmidt C., Poch A.et al. Production and action of C-type natriuretic peptide in the gonadotrope-derived αT3-1 cell line. Endocrine. 2:1994;849-856.
39. McArdle C.A., Poch A., Kappler K. Cyclic guanosine monophosphate production in the pituitary: stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing hormone in alpha T3-1cells. Endocrinology. 132:1993;2065-2072.
40. Lelievre V., Pineau N., Hu Z., Ioffe Y., Byun J.-Y., Muller J.-M.et al. Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. J. Biol. Chem. 276:2001;43668-43676.
41. Kim N.N., Huang Y.-H., Moreland R.B., Kwak S.S., Goldstein I., Traish A. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol. Cell Biol. Res. Commun. 4:2000;10-14.
42. Schwartz J.H. The many dimensions of cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 98:2001;13482-13484.